Transwell assays further demonstrated that upregulated or downregulated expression of AGGF1 could also strengthen or attenuate the migration and invasion ability, respectively, of CRC cells in vitro (p < 0.05 for all, Fig. 3d). Here, AGGF1 is linked to colorectal carcinoma.